Dxcover Announces Expansion of Its Leadership Team to Support Advancement of its Multi-Cancer Liquid Biopsy Platform
Under his guidance, he will support the company’s business operations and long-term objectives, focusing on strategy, performance, and value creation.
- Under his guidance, he will support the company’s business operations and long-term objectives, focusing on strategy, performance, and value creation.
- Andrews brings more than three decades of experience in the diagnostic space in various senior commercialization roles.
- Prior to that he held leadership positions at The Bethesda Group, Thermo Fisher Scientific, GE, Roche Diagnostics, Abbott Diagnostics, amongst others.
- Chick brings diagnostic and pharmaceutical commercialization experience as former CCO at Inivata and progressive leadership roles at Sanofi and BMS.